FDA clears Combinostics’ MRI quantification software cNeuro cMRI

Jan 15, 2018

Tampere January 15, 2018 – The digital health company Combinostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its image quantification software cNeuro cMRI. The software enables clinicians to get objective measurements of atrophy in...